CGRP receptor antagonists

Details for Australian Patent Application No. 2010306954 (hide)

Owner Bristol-Myers Squibb Company

Inventors Luo, Guanglin; Dubowchik, Gene M.; Macor, John E.

Agent A J Park

Pub. Number AU-A-2010306954

PCT Pub. Number WO2011/046997

Priority 61/251,477 14.10.09 US

Filing date 13 October 2010

Wipo publication date 21 April 2011

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61K 31/473 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines

A61K 31/4745 (2006.01)

A61K 31/4747 (2006.01) - spiro-condensed

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 25/06 (2006.01) Drugs for disorders of the nervous system

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 471/10 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 471/20 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

3 May 2012 PCT application entered the National Phase

  PCT publication WO2011/046997 Priority application(s): WO2011/046997

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010306961-Paraplegia prevention stent graft

2010306940-Methods and compositions for modulating gene expression using oligonucleotide based drugs administered in vivo or in vitro